• From RNA Delivery to RNA Readout: Better Labeling

  2026-09-25

  Lipid nanoparticle size can shape mRNA uptake and expression, but delivery studies also need dependable ways to visualize RNA. This article connects simulation-guided LNP design with Cy5-UTP RNA probe synthesis—and explains why fluorescent probe readouts complement, but do not replace, functional delivery measurements.

• Saquinavir Beyond Target Potency: Membrane Context

  2026-09-25

  Saquinavir’s value in translational research is clearest when target inhibition is interpreted alongside membrane interaction and exposure. A comparison of biomimetic chromatography methods offers a practical framework for choosing complementary permeability tools—while also defining what those methods cannot establish about Saquinavir.

• Fungal IAA Regulates Ferroptotic Conidial Death

  2026-09-24

  A 2026 study in *Magnaporthe oryzae* identifies fungus-derived indole-3-acetic acid (IAA) as a regulator of iron and lipid peroxide accumulation during developmental conidial death. Genetic and lipid-rescue results connect IAA-dependent lipid metabolism and autophagy with appressorium development and pathogenicity, while leaving important questions about the underlying molecular steps open.

• GS967 and the Electrical-Mechanical Aging Axis

  2026-09-24

  Explore how GS967, a cardiac late sodium current inhibitor, can help test the link between abnormal electrical recovery and impaired relaxation in cardiac aging. This article interprets recent Nav1.5 Ser571 findings as a guide to choosing complementary electrophysiology, calcium-handling, and mechanical readouts.

• Cy5 RNA Labeling Kit for Tumor RNA Assays

  2026-09-23

  Connect tumor biology to spatial RNA detection with a fluorescent probe workflow that can be tuned for labeling density and transcription yield. The HyperScribe kit supports probe preparation for in situ hybridization and Northern blots; it does not test or reproduce the nanoparticle-mediated mRNA delivery described in the reference study.

• Doxorubicin and Persister-Cell Ferroptosis

  2026-09-23

  Doxorubicin is more than a DNA-damaging cancer chemotherapy drug: it can help interrogate how treatment-tolerant persister cells acquire exploitable ferroptosis sensitivity. This article translates recent lipidomic findings into practical, state-aware assay design for hematologic malignancy research and solid-tumor models.

• Saquinavir: From Protease Potency to Permeability

  2026-09-22

  A translational framework for using Saquinavir to connect HIV protease inhibition with biomimetic membrane-interaction studies, while maintaining rigorous boundaries around permeability, antiretroviral research, and exploratory cancer applications.

• FK866: A Causal Probe of NAD–PARP1 Biology

  2026-09-22

  FK866 (APO866) is more than a cytotoxic NAMPT inhibitor: it is a powerful causal probe for linking NAD depletion to mitochondrial dysfunction, DNA damage, and cellular senescence. This article translates recent NAMPT/PARP1 findings into practical assay strategies for hematologic cancer research and carefully bounded vascular-aging studies.

• Dlin-MC3-DMA LNP Workflow and Optimization Guide

  2026-09-21

  Dlin-MC3-DMA provides a practical ionizable cationic liposome platform for controlled siRNA delivery, hepatic gene silencing, and mRNA vaccine formulation. This workflow connects pH-responsive chemistry with machine-learning-guided formulation choices, helping researchers troubleshoot potency, particle quality, and viability artifacts.

• Deoxycholic Acid in Translational Cancer Research

  2026-09-21

  A translational framework for using Deoxycholic acid sodium salt as a controlled chemical perturbation alongside SNORA38B, GAB2/AKT/mTOR, and immune checkpoint studies in non-small cell lung cancer.

• NAD+ in Stress-Response Assays

  2026-09-20

  Explore how Nicotinamide Adenine Dinucleotide (NAD+) can sharpen interpretation of autophagy, PARP1, and DNA-damage assays. This article connects NAD+ biochemistry with new evidence on non-lethal caspase signaling while separating established findings from experimental hypotheses.

• Cholesterol in Translational mRNA-LNP Strategy

  2026-09-19

  Cholesterol is more than a membrane excipient: it is a tunable design variable for mRNA-LNP stability, delivery, and translational reproducibility. This thought-leadership article connects cholesterol biology with the intravesical p21 mRNA-LNP bladder cancer study and outlines practical formulation, assay, and development priorities.

• Saquinavir Workflows for HIV Protease Research

  2026-09-18

  Use Saquinavir as a controlled HIV protease inhibitor benchmark while connecting enzymatic potency with membrane interaction and permeability measurements. This workflow combines practical stock handling, biomimetic chromatography, mass spectrometry, and troubleshooting for reproducible antiretroviral drug research.

• Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance

  2026-09-18

  The reference study developed a tumor-microenvironment-responsive nanoparticle for systemic delivery of PTEN mRNA in trastuzumab-resistant HER2-positive breast cancer. By restoring PTEN and suppressing persistently active PI3K/Akt signaling, the platform improved trastuzumab responsiveness and reduced tumor progression in preclinical models.

• Apigenin: From HDAC Biology to Network Medicine

  2026-09-17

  Apigenin connects epigenetic tumor biology with network-based neuroprotection. This thought-leadership guide interprets the evidence, defines practical assay parameters, and outlines a translational strategy for researchers studying malignant mesothelioma, Alzheimer’s disease, apoptosis, inflammation, and oxidative stress.

644 records 1/43 page Next 12345 下5页 Last page